The North America respiratory inhalers market is expected to witness substantial growth, with a projected CAGR of 5.90% from 2024 to 2032. This market growth is largely attributed to the rising prevalence of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), increasing healthcare spending, and innovations in inhaler technologies. This blog explores these […]